NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
13/12/2022
Voltar para busca
Dado oficial do USPTO
L2P RESEARCH
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
37
Atualização mais recente
13/12/2022
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
42
Data de depósito
02/01/2020
Data de registro
13/12/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
13/12/2022
Última transação
13/12/2022
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
10/08/2018
Primeiro uso no comércio
10/08/2018
Código do desenho
4
Tipo de titular
16
Localização do titular
Annville, PA, US
Examinador
HILL, JAMES T
Unidade examinadora
M70
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Lab TO Pharmacy, LLC
Representantes
James F. Harrington Hoffmann & Baron, LLP
Classificação técnica
Classes Nice
Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 42
Research and development in the pharmaceutical and biotechnology fields; Research and development of advanced learning technologies and teaching methods; Research and development of new products; Research and development of new products for others; Research and development of vaccines and medicines; Research and development services in connection with physics; Research and development services in the field of antibodies; Research in the area of semiconductor processing technology; Research in the field of chemistry; Research on the subject of pharmaceuticals; Agrochemical research services; Bacteriological research; Bacteriological consultation and research; Biochemical research; Biochemical research and development; Biological research; Biomedical research services; Biotechnology research; Chemical research; Conducting clinical trials for others; Consulting services in the field of hydrological research; DNA analysis services for scientific research purposes; DNA screening for scientific research purposes; Genetic testing for scientific research purposes; Genetic testing of laboratory animals for research purposes; Genotyping services for research or analysis purposes; Industrial research in the field of Biotechnology; Industrial research in the field of Immunology; Integrated scientific research on vermin for greenhouses and harvest crops; Laboratory research services relating to pharmaceuticals; Medical research services in the field of cancer; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research in the field of medical imaging; Medical and scientific research in the field of Oncology; Medical and scientific research in the field of Cancer; Medical and scientific research in the field of Nature Therapeutics; Pharmaceutical research and development; Pharmaceutical research services; Product research; Product research and development; Providing information in the field of plant genetics research resources; Providing medical research and scientific research information in the field of oncology via the Internet; Providing scientific research information in the field of Tumor Immunology; Providing scientific research information in the field of Pre clinical Research; Providing scientific research information in the field of Animal Research; Scientific research; Scientific research and development; Scientific research consulting in the field of cosmetics; Scientific research consulting in the field of in vitro fertilization; Scientific research for medical purposes in the area of cancerous diseases; Scientific and technological research relating to patent mapping; Technical research in the field of pharmaceutical studies; Testinginspection or research of pharmaceuticalscosmetics or foodstuff; Zoological research and consultation
Publicações
Histórico de despachos e eventos da marca no USPTO.
37 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
13/12/2022
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
10/11/2022
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
09/11/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/11/2022
DPCC
DIVISIONAL PROCESSING COMPLETE
03/11/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
25/10/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
01/08/2022
IUAF
USE AMENDMENT FILED
07/07/2022
DRRR
DIVISIONAL REQUEST RECEIVED
07/07/2022
EISU
TEAS STATEMENT OF USE RECEIVED
07/07/2022
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
07/07/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/01/2022
EX3G
SOU EXTENSION 3 GRANTED
06/01/2022
EXT3
SOU EXTENSION 3 FILED
06/01/2022
EEXT
SOU TEAS EXTENSION RECEIVED
06/01/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/07/2021
EX2G
SOU EXTENSION 2 GRANTED
07/07/2021
EXT2
SOU EXTENSION 2 FILED
07/07/2021
EEXT
SOU TEAS EXTENSION RECEIVED
07/07/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/01/2021
EX1G
SOU EXTENSION 1 GRANTED
06/01/2021
EXT1
SOU EXTENSION 1 FILED
06/01/2021
EEXT
SOU TEAS EXTENSION RECEIVED
06/01/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
07/07/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/05/2020
PUBO
PUBLISHED FOR OPPOSITION
12/05/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
22/04/2020
ALIE
ASSIGNED TO LIE
02/04/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
24/03/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
24/03/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
24/03/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
24/03/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
24/03/2020
DOCK
ASSIGNED TO EXAMINER
24/03/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/01/2020
NWAP
NEW APPLICATION ENTERED
06/01/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace L2P RESEARCH ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.